Yara International ASA (YARIY) Q2 2025 Presentation Call Transcript

Yara International reported robust Q2 2025 results, with EBITDA (excluding special items) up 27% to $652 million and H1 adjusted EPS more than tripling to $1.92, driven by strong commercial performance, supportive market fundamentals, and record production. The company's cost and CapEx reduction programs are ahead of schedule, contributing to lower fixed costs and a $126 million increase in free cash flow, with Q2 ROIC reaching 9.9%. Strategically, Yara is leveraging its ammonia import flexibility to mitigate high European gas costs and is evaluating a potential equity investment in U.S. ammonia projects by H1 2026, while also noting favorable long-term market fundamentals for urea.

Analysis

Yara International ASA reported a robust second quarter, with EBITDA excluding special items rising 27% year-over-year to $652 million, driven by a combination of supportive market fundamentals and strong commercial execution. Adjusted earnings per share for the first half more than tripled to $1.92 from $0.64 a year prior, underscoring significant profitability improvements. This performance was underpinned by record underlying production levels and sustained high premiums on both nitrate and NPK products. Operationally, the company is executing its improvement program ahead of schedule, realizing a $46 million reduction in fixed costs for the quarter and lowering its full-year 2025 CapEx guidance by an additional $100 million to $1.1 billion. This disciplined approach contributed to a $126 million increase in free cash flow despite higher inventory values. Consequently, quarterly return on invested capital (ROIC) reached 9.9%, nearing the company's 10% through-the-cycle target. Strategically, Yara is leveraging its extensive ammonia import infrastructure to mitigate structurally higher European gas costs, a key competitive advantage. The company is also evaluating a potential equity investment in U.S. ammonia production, with a final decision expected in H1 2026, aiming for double-digit returns without shareholder dilution. The market outlook remains favorable, with management citing firm, demand-driven fundamentals for urea and a tight supply outlook towards 2030.

Key Decisions for Investors

• Investors should recognize the company's demonstrated ability to execute on its cost-cutting and capital discipline programs, which are delivering ahead of targets and directly enhancing free cash flow and profitability.
• The strategic move to leverage ammonia import flexibility and a potential U.S. upstream investment represents a significant de-risking of European operations from volatile gas prices and could be a key driver of future margin expansion; monitor the H1 2026 final investment decision closely.
• Given the positive commodity cycle outlook presented by management, maintaining a bullish stance could be warranted, but positions should be managed with an eye on key variables like Chinese export quotas and European energy prices.
• Note that while quarterly ROIC is strong at 9.9%, the 12-month rolling figure remains below target, indicating that continued progress on asset optimization, particularly in Europe, is necessary to achieve sustained high returns.